AR054590A1 - Composiciones topicas anti pruriginosas y metodos de accion de las mismas - Google Patents

Composiciones topicas anti pruriginosas y metodos de accion de las mismas

Info

Publication number
AR054590A1
AR054590A1 ARP060103268A ARP060103268A AR054590A1 AR 054590 A1 AR054590 A1 AR 054590A1 AR P060103268 A ARP060103268 A AR P060103268A AR P060103268 A ARP060103268 A AR P060103268A AR 054590 A1 AR054590 A1 AR 054590A1
Authority
AR
Argentina
Prior art keywords
pruritic
compositions
methods
pruritus
pruriginal
Prior art date
Application number
ARP060103268A
Other languages
English (en)
Inventor
Kathleen L Clark
Joanne M Fraser
Original Assignee
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Laboratories filed Critical Stiefel Laboratories
Publication of AR054590A1 publication Critical patent/AR054590A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones topicas anti-pruriginosas y métodos para usarlas para tratar el prurito. Estas composiciones anti-pruriginosas son capaces de reducir, inhibir, tratar, mejorar y/o prevenir en forma temporaria o permanente las condiciones de prurito de la piel así como también otras afecciones de la piel relacionadas. En un aspecto particular, las presentes formulaciones proveen un tratamiento más rápido y más efectivo del prurito que ciertas composiciones actuales para el tratamiento del prurito. Reivindicacion 1: Una composicion topica anti-pruriginosa que comprende: (i) una cantidad terapéuticamente efectiva de un agente anti- pruriginoso; (ii) entre alrededor de 1 y alrededor de 10% en peso de un agente oclusivo acondicionante de la piel; (iii) entre alrededor de 0,5 y alrededor de 5% en peso de un organosiloxano; y (iv) un solvente acuoso.
ARP060103268A 2005-07-27 2006-07-27 Composiciones topicas anti pruriginosas y metodos de accion de las mismas AR054590A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/190,050 US20070027152A1 (en) 2005-07-27 2005-07-27 Topical anti-pruritic compositions and methods of action of same

Publications (1)

Publication Number Publication Date
AR054590A1 true AR054590A1 (es) 2007-06-27

Family

ID=37726969

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103268A AR054590A1 (es) 2005-07-27 2006-07-27 Composiciones topicas anti pruriginosas y metodos de accion de las mismas

Country Status (3)

Country Link
US (2) US20070027152A1 (es)
AR (1) AR054590A1 (es)
WO (1) WO2007016156A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
GB2549429B (en) * 2014-12-23 2021-04-14 Kimberly Clark Co Skin-protective emulsions
US20170056332A1 (en) * 2015-08-28 2017-03-02 C.B. Fleet Company, Incorporated Hemorrhoid preparation and sheets

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172805A (en) * 1962-07-12 1965-03-09 Colgate Palmolive Co Anesthetic preparations containing potentiated 4[3-(p-butoxyphenoxy)-propyl morpholine; 3-butyl-1-(2-dimetylamino ethoxy) isoquinoline; 2-dimethylamino-2' 6'-acetoxylidide
US4389418A (en) * 1981-02-25 1983-06-21 S. C. Johnson & Son, Inc. Skin care composition
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
US4970220A (en) * 1982-05-17 1990-11-13 S. C. Johnson & Son, Inc. Skin conditioning composition
US5332689A (en) * 1993-02-17 1994-07-26 Micron Technology, Inc. Method for depositing low bulk resistivity doped films
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
WO1996012467A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5849310A (en) * 1994-10-20 1998-12-15 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5576346A (en) * 1995-04-03 1996-11-19 Ascent Pharmaceuticals, Inc. Process for treating uremic pruritus
US5607980A (en) * 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US5665364A (en) * 1995-07-24 1997-09-09 The Procter & Gamble Company Compositions for topical delivery of active ingredients
US6086903A (en) * 1996-02-26 2000-07-11 The Proctor & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US5811114A (en) * 1996-06-12 1998-09-22 E-L Management Corp. Stabilized hinokitiol and compositions containing same
US5976556A (en) * 1996-06-13 1999-11-02 Active Organics, Inc. Combination of acid protease enzymes and acidic buffers and uses thereof
US5961997A (en) * 1997-03-25 1999-10-05 Swinehart; James M. Antipruritic composition
US6599513B2 (en) * 1997-05-27 2003-07-29 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
EP0884045A1 (en) * 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
CA2302444C (en) * 1997-09-05 2007-04-10 The Procter & Gamble Company Cleansing and conditioning products for skin or hair with improved deposition of conditioning ingredients
BR9811789A (pt) * 1997-09-12 2000-09-05 Procter & Gamble Artigo de limpeza e condicionamento para tratamento pessoal de utilização única, descartável e processos para manufaturar esse artigo e para limpar e condicionar a pele ou cabelo com esse artigo
US6214889B1 (en) * 1997-11-17 2001-04-10 Thomas E. Peterson Topical application of formate for relief of adverse skin condition for humans
KR20010041902A (ko) * 1998-03-16 2001-05-25 데이비드 엠 모이어 포유류의 피부 내의 셀룰라이트를 감소시키는 방법
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6423329B1 (en) * 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US6656701B2 (en) * 1999-07-16 2003-12-02 Actim Organics, Inc Combination of acid protease enzymes and acidic buffers and uses thereof
US6428799B1 (en) * 1999-08-02 2002-08-06 The Procter & Gamble Company Personal care articles
US6217889B1 (en) * 1999-08-02 2001-04-17 The Proctor & Gamble Company Personal care articles
US6322801B1 (en) * 1999-08-02 2001-11-27 The Procter & Gamble Company Personal care articles
US6267975B1 (en) * 1999-08-02 2001-07-31 The Procter & Gamble Company Personal care articles
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
EP1166225A1 (en) * 2000-01-31 2002-01-02 Collaborative Technologies, Inc. Method and system for producing customized cosmetic and pharmaceutical formulations on demand
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
US6777450B1 (en) * 2000-05-26 2004-08-17 Color Access, Inc. Water-thin emulsions with low emulsifier levels
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
CA2474058A1 (en) * 2002-01-25 2003-07-31 Mariana De Oliveira Composition for and method of treatment for skin ailments
US6667026B1 (en) * 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
US6964782B1 (en) * 2002-07-23 2005-11-15 Tec Labs, Inc. Stable hydrogen peroxide compositions, products and methods of use
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
US20040258719A1 (en) * 2003-06-19 2004-12-23 Yuichiro Takahashi External preparation for treating dermatosis and pruritus due to hemodialysis
US20060004094A1 (en) * 2004-07-02 2006-01-05 Agisim Gary R Composition and method for treating hemorrhoids and/or anorectal disorders

Also Published As

Publication number Publication date
WO2007016156A3 (en) 2007-10-04
US20070027152A1 (en) 2007-02-01
US10118055B2 (en) 2018-11-06
US20110237593A1 (en) 2011-09-29
WO2007016156A2 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
AR058821A1 (es) Metodos, sistemas y composiciones de tratamiento graduables por el usuario para el tratamiento del acne
MX2019015578A (es) Metodos para tratar la enfermedad de huntington.
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
CL2017000998A1 (es) Composición que comprende un agente de control biológico de la especie bacillus subtilis y un fungicida del grupo de inhibidores de la mitosis y la división celular, tal como fenamidona. (divisional solicitud 3272-2014)
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
CL2013003016A1 (es) Una composicion oftalmica topica para el tratamiento y/o la profilaxis de una infeccion producida por un microorganismo o un trastorno de al menos un tejido ocular, que comprende a) 0,01 a 10% de povidona yodada y b) un esteroide seleccionado de acetato de prednisolona, etabonato de loteprednol, difluprednato, entre otros, o bromfenaco.
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
WO2012065958A9 (en) Method of treating contrast-induced nephropathy
RS54548B1 (en) COMPOSITIONS CONTAINING ORGANIC ACID MONOGLICERIDES WITH C1 TO C7 AND GLYCEROL, THEIR PREPARATION AND USE AS ANTIBACTERIAL AND ANTIGLIVIC AGENAS
BR112013018352A2 (pt) composição de minociclina tópica e método
AR076040A1 (es) Composicion que comprende al menos un compuesto flavonoide, con la condicion de que el compuesto flavonoide no sea hesperetina, y hesperetina
BR112015016997A2 (pt) composto, composição farmacêutica e método para o tratamento ou prevenção de câncer de mama
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
PE20121709A1 (es) Una composicion farmaceutica para tratar cancer que comprende tripsinogeno y/o quimotripsinogeno y un agente activo seleccionado a partir de un compuesto de selenio, un compuesto vainilloide y un agente reductor de glicolisis citoplasmica
UY31780A (es) Fenoxibenzamidas sustituidas
MX350595B (es) Composiciones organicas para tratar enfermedades relacionadas con beta-enac.
EA201401031A1 (ru) Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей
MX2016017403A (es) Composiciones y metodos topicos para el tratamiento de heridas.
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
CU20080054A7 (es) Composiciones con suplemento de hierro con tolerancia mejorada
AR048587A1 (es) Composiciones quimicamente estables de 4-hidroxitamoxifeno
AR054590A1 (es) Composiciones topicas anti pruriginosas y metodos de accion de las mismas
EA201071369A1 (ru) Композиции для лечения выпадения волос

Legal Events

Date Code Title Description
FA Abandonment or withdrawal